Clorox vs Haleon
CLX and HLN side by side, both in soap, detergents, and cleaning preparations; perfumes, cosmetics, and other toilet preparations. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.
How CLX and HLN compare
Haleon grew revenue faster over the last twelve months (−1.8% versus −5.4% for Clorox).
Haleon keeps more of each dollar of sales as profit, with a net margin of 15.1% compared with 8.7% at Clorox.
Clorox pays a dividend yielding 3.5%; Haleon does not pay one.
Clorox scores higher on the StockData Score (13 against 9 for Haleon), which adds up 30 checks on valuation, growth, past performance, financial health and dividends.
Key numbers
A dot marks the better figure where higher or lower is clearly better.
| Metric | CLX | HLN |
|---|---|---|
| Size and price | ||
| Market cap | $12.9B | – |
| Share price | $106.70 | $9.05 |
| Change, 1 year | 2.9% | −5.6% |
| Change, 5 years | −38.8% | – |
| Beta (5Y) | 0.42 | −0.02 |
| Employees | 9,200 | – |
| StockData Score | ||
| Total score | 13 (better) | 9 |
| Valuation score | 5 (better) | 0 |
| Growth score | 2 | 3 (better) |
| Performance score | 4 | 4 |
| Health score | 0 | 2 (better) |
| Dividend score | 2 (better) | 0 |
| Valuation | ||
| P/E | 22.2× | – |
| P/S | 1.9× | – |
| P/B | 143× | – |
| EV/EBITDA | 15.4× | – |
| P/FCF | 31.9× | – |
| PEG | 0.38 | – |
| FCF yield | 3.1% | – |
| Fair value | $153.42 | – |
| Margin of safety | 30.5% | – |
| Growth | ||
| Revenue growth (TTM) | −5.4% | −1.8% (better) |
| Revenue growth, 5Y average | −1.8% | 2.2% (better) |
| Net income growth (TTM) | −27.5% | 15.6% (better) |
| EPS growth (TTM) | −26.2% | 17.8% (better) |
| EPS growth, 5Y average | −2.9% | 8.3% (better) |
| Profitability | ||
| Gross margin | 42.3% | 64.2% (better) |
| Operating margin | – | 21.9% |
| Net margin | 8.7% | 15.1% (better) |
| FCF margin | 6.0% | 21.0% (better) |
| Return on equity | 286% (better) | 10.2% |
| Return on invested capital | – | 7.9% |
| Financial health | ||
| Debt / equity | 56.31 | 0.50 (better) |
| Net debt / EBITDA | 4.22 | 2.68 (better) |
| Interest coverage | – | 7.1× |
| Current ratio | 0.66 | 0.69 (better) |
| Altman Z-score | 1.81 | – |
| Piotroski F-score | 3 | 7 (better) |
| Dividends and buybacks | ||
| Dividend yield | 3.5% | – |
| Payout ratio | 103% | – |
| Years of dividend growth | 17 | – |
| Dividend growth, 5Y average | 2.2% | – |
| Buyback yield | 2.0% | – |
| Shareholder yield | 5.5% | – |
| Ownership | ||
| Held by institutions | 86.3% | 6.7% |
| Held by insiders | 0.68% | 0.00% |
| Insider net buying, 12 months | $829K | – |
| Superinvestors holding | 2 | 2 |
| Short interest, % of float | 9.0% | – |
Go deeper
- CLX stock overview
- CLX income statement
- CLX valuation and score
- HLN stock overview
- HLN income statement
- HLN valuation and score
Other comparisons
For information only, not investment advice. Check the source filings before relying on any figure.